Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have received an average rating of “Hold” from the five brokerages that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $4.00.
Several equities analysts have recently commented on the company. Canaccord Genuity Group lowered their price objective on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating on the stock in a research report on Friday, January 2nd. Wall Street Zen raised shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Weiss Ratings restated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Finally, Oppenheimer lowered shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research report on Wednesday, October 22nd.
Read Our Latest Analysis on BIOX
Institutional Inflows and Outflows
Bioceres Crop Solutions Stock Up 7.5%
Shares of BIOX stock opened at $0.63 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.94 and a quick ratio of 0.64. Bioceres Crop Solutions has a one year low of $0.53 and a one year high of $5.44. The company’s fifty day moving average price is $1.22 and its 200-day moving average price is $1.83. The company has a market capitalization of $39.71 million, a price-to-earnings ratio of -0.75 and a beta of 0.50.
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.
Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- Is THIS the Next Big Money Rush?
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
